Stay updated with breaking news from Master File. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ocugen has submitted key information and data to date including preclinical studies, chemistry, manufacturing, and controls (CMC), and clinical studies as a Master File for FDA review and input prior to a planned EUA submission.
URL copied Covaxin has reached 30 cities in the past 30 days Covaxin, India's indigenous Covid-19 vaccine, has reached 30 cities in the past 30 days, said the vaccine manufacturer Bharat Biotech in a statement on Tuesday. Among 30 cities that have received the Covaxin doses include Delhi, Kolkata, Mumbai, Chennai, Bengaluru, Kochi and Amritsar. Covaxin is one of the three vaccines that the DGCI has cleared for emergency use in India. The two others are Covishield and Sputnik V. While Covishield is the local version of Oxford-AstraZeneca COVID-19 vaccine and being manufactured by Pun...
Bharat Biotech's US partner Ocugen submits 'Master File' to FDA on Covaxin Ocugen has submitted key information and data to date as a Master File for FDA review and input prior to a planned EUA submission. Share Via Email | A+A A- By PTI HYDERABAD: Ocugen, Bharat Biotech's American partner for COVID-19 vaccine Covaxin, has submitted a "Master File" to the US Food and Drug Administration prior to seeking an emergency use authorisation in that country. "The company is currently evaluating the clinical and regulatory path for COVAXIN in the United States including obtaining Emergen...
Bharat Biotech expects WHO nod for Covaxin in Sept quarter BusinessToday.In © India Today Group Bharat Biotech expects WHO nod for Covaxin in Sept quarter Hyderabad-based Bharat Biotech has confirmed that it has submitted application for emegency use listing (EUL) of its coronavirus vaccine Covaxin before the World Health Organisation. The Indian vaccine manufacturer expects the global health agency to grant the same within July to September period this year. A guidance document updated last week on WHO's official website showed that Bharat Biotech submitted expression of ...
COVID-19 vaccine: Bharat Biotech's US partner Ocugen submits 'Master File' on Covaxin to FDA Ocugen has submitted key information and data to date including preclinical studies, chemistry, manufacturing, and controls (CMC), and clinical studies as a Master File for FDA review and input prior to a planned EUA submission PTI | May 25, 2021 | Updated 14:47 IST Ocugen, Bharat Biotech's American partner for COVID-19 vaccine Covaxin, has submitted a "Master File" to the US Food and Drug Administration prior to seeking an emergency use authorisation in that country. "The company is currently evalu...